Literature DB >> 16214096

The immune response to citrullinated antigens in autoimmune diseases.

P Migliorini1, F Pratesi, C Tommasi, C Anzilotti.   

Abstract

Post-translational modifications of proteins occur very frequently. One of these modifications, citrullination, is the result of arginine deimination operated by an enzyme, peptidylarginine deiminase (PAD), whose activity is under strict genetic control. Serum antibodies reactive with citrullinated proteins/peptides are a very sensitive and specific marker for rheumatoid arthritis. Genes encoding for PAD enzymes have been investigated in RA: the PADI4 gene confers susceptibility to RA in Japanese patients, but not in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214096     DOI: 10.1016/j.autrev.2005.04.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  6 in total

Review 1.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

2.  Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosis.

Authors:  E Aigner; I Schmid; C H Osterreicher; J Zwerina; G Schett; M Strasser; F Niksic; F Hohla; T Ramsauer; U Dorn; W Patsch; C Datz
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

3.  A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.

Authors:  Sharad Kholia; Samireh Jorfi; Paul R Thompson; Corey P Causey; Anthony P Nicholas; Jameel M Inal; Sigrun Lange
Journal:  J Extracell Vesicles       Date:  2015-06-19

Review 4.  Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?

Authors:  Sigrun Lange; Mark Gallagher; Sharad Kholia; Uchini S Kosgodage; Mariya Hristova; John Hardy; Jameel M Inal
Journal:  Int J Mol Sci       Date:  2017-06-05       Impact factor: 5.923

5.  Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.

Authors:  Paul Proost; Tamara Loos; Anneleen Mortier; Evemie Schutyser; Mieke Gouwy; Samuel Noppen; Chris Dillen; Isabelle Ronsse; René Conings; Sofie Struyf; Ghislain Opdenakker; Prabhat C Maudgal; Jo Van Damme
Journal:  J Exp Med       Date:  2008-08-18       Impact factor: 14.307

Review 6.  Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers.

Authors:  Shuzo Sato; Jumpei Temmoku; Yuya Fujita; Makiko Yashiro-Furuya; Naoki Matsuoka; Tomoyuki Asano; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2020-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.